Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This treatment plan is intended for the use of UX007 (triheptanoin) in the treatment of a
single patient with Glucose Transporter 1 (GLUT1) Deficiency Syndrome.